Losartan potassium

An AT1 receptor antagonist (Ki = 5-20 nM) attenuates vein graft atherosclerosis in rabbits and reduces arterial blood pressure in rats controls hypertension while protecting renal function, in humans.

An AT1 receptor antagonist (Ki = 5-20 nM) attenuates vein graft atherosclerosis in rabbits and reduces arterial blood pressure in rats controls hypertension while protecting renal function, in humans.

An AT1 receptor antagonist (Ki = 5-20 nM) attenuates vein graft atherosclerosis in rabbits and reduces arterial blood pressure in rats controls hypertension while protecting renal function, in humans.

An AT1 receptor antagonist (Ki = 5-20 nM) attenuates vein graft atherosclerosis in rabbits and reduces arterial blood pressure in rats controls hypertension while protecting renal function, in humans.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

Losartan potassium has long lasting effects, and its efficacy is generally increased, when combined with the diuretic co-active hydrochlorothiazide. Losartan potassium is an antihypertensive drug that is found to be an angiotensin II receptor type

Losartan potassium has long lasting effects, and its efficacy is generally increased, when combined with the diuretic co-active hydrochlorothiazide. Losartan potassium is an antihypertensive drug that is found to be an angiotensin II receptor type

Biochem/physiol Actions Losartan potassium is an orally available, potent, and selective competitive angiotensin II receptor type 1 (AT1) antagonist. Losartan potassium is used for treatment of hypertension.

Biochem/physiol Actions Losartan potassium is an orally available, potent, and selective competitive angiotensin II receptor type 1 (AT1) antagonist. Losartan potassium is used for treatment of hypertension.

General description Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Losartan

Losartan potassium is a new drug used for hypertension. It is nonpeptide angiotensin II (AII) receptor antagonist.Losartan potassium is nonpeptide angiotensin II (AII) receptor antagonist and is orally active. It belongs to a new class of drugs